Croda International Given Outperform Rating at Credit Suisse (CRDA)
Croda International (LON:CRDA)‘s stock had its “outperform” rating reaffirmed by Credit Suisse in a research note issued on Wednesday, Analyst RN reports. They currently have a GBX 3,000 ($48.13) price target on the stock. Credit Suisse’s price objective indicates a potential upside of 14.55% from the company’s current price.
CRDA has been the subject of a number of other recent research reports. Analysts at Bank of America Corp. reiterated a “buy” rating on shares of Croda International in a research note to investors on Wednesday. They now have a GBX 2,870 ($46.05) price target on the stock. Separately, analysts at BNP Paribas reiterated an “outperform” rating on shares of Croda International in a research note to investors on Tuesday. They now have a GBX 3,200 ($51.34) price target on the stock. Finally, analysts at Barclays Capital raised their price target on shares of Croda International from GBX 2,520 ($40.43) to GBX 2,600 ($41.71) in a research note to investors on Thursday, October 3rd. They now have an “underweight” rating on the stock. Four research analysts have rated the stock with a sell rating, five have issued a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of GBX 2,651.78 ($42.54).
Croda International (LON:CRDA) traded down 1.83% on Wednesday, hitting GBX 2571.00. The stock had a trading volume of 130,343 shares. Croda International has a 1-year low of GBX 1998.0499 and a 1-year high of GBX 2846.00. The stock has a 50-day moving average of GBX 2603.13 and a 200-day moving average of GBX 2569.31. The company’s market cap is £3.473 billion.
Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.